Kenporen Proposes Excluding OTC-Like Pollinosis Drugs from Health Coverage, Expecting Annual Savings of 60 Billion Yen

Kenporen Director Shoji Kono at a press conference on August 23 The National Federation of Health Insurance Societies (Kenporen) announced on August 23 its proposals for the FY2020 medical fee revision, calling for OTC-like ethical drugs for the treatment of...read more